• Rashed O Alqaisi, Waqar A Al-Kubaisy, Shahed N Abughanam, Areen Z Alfalayleh, and Mohamad-Said H Almasri.
• From the Department of Public Health (Al-Kubaisy), Mutah University, Al-Karak; and from Ministry of Health (Almasri, Alfalayleh, Abughanam), Irbid, Jordan.
• Saudi Med J. 2023 Oct 1; 44 (10): 105410601054-1060.

ObjectivesTo investigate the occurrence and identify the factors contributing to hospitalization among individuals diagnosed with COVID-19.MethodsFrom June 15, 2020 to September 30, 2020, a cross-sectional study utilizing an online questionnaire was carried out in Jordan. The study included 657 COVID-19 patients who had recovered and had reached a minimum of 3 months post-illness. Sociodemographic and COVID-19-related data were collected. The questionnaire was distributed to members of the "My Experience with COVID-19 Association" in Jordan.ResultsThe prevalence of hospitalization among COVID-19 patients was 3%. Patients with hypertension (p=0.00), diabetes mellitus (p=0.00), and heart disease (p=0.009); using angiotensin-converting enzyme inhibitors (ACE) and angiotensin-receptor blockers (ARBs) (p=0.00); with body mass indexes (BMI) above normal (p=0.005); and aged over 45 years (p=0.00) were at higher risk of hospitalization. Using an odds ratio (OR), hypertension (OR=7.1), diabetes mellitus (OR=11.4), heart disease (OR=6.3), angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers use (OR=10.8), and having a BMI >25 (OR=5) were significant hospitalization risk factors. The seasonal influenza vaccine, smoking, and neuropsychological symptoms showed no significance.ConclusionIdentifying high-risk groups can help them monitor their health and take preventive measures against COVID-19 infection.Copyright: © Saudi Medical Journal.

24 keywords...

hide…